JP2020505928A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505928A5 JP2020505928A5 JP2019541445A JP2019541445A JP2020505928A5 JP 2020505928 A5 JP2020505928 A5 JP 2020505928A5 JP 2019541445 A JP2019541445 A JP 2019541445A JP 2019541445 A JP2019541445 A JP 2019541445A JP 2020505928 A5 JP2020505928 A5 JP 2020505928A5
- Authority
- JP
- Japan
- Prior art keywords
- pca
- individual
- pcags
- psa
- snp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022140682A JP2022179483A (ja) | 2017-02-01 | 2022-09-05 | 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1750080-2 | 2017-02-01 | ||
| SE1750080 | 2017-02-01 | ||
| PCT/EP2018/052473 WO2018141828A1 (en) | 2017-02-01 | 2018-02-01 | Method for indicating a presence or non-presence of prostate cancer in individuals with particular characteristics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022140682A Division JP2022179483A (ja) | 2017-02-01 | 2022-09-05 | 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020505928A JP2020505928A (ja) | 2020-02-27 |
| JP2020505928A5 true JP2020505928A5 (cg-RX-API-DMAC10.html) | 2021-08-12 |
| JP7138112B2 JP7138112B2 (ja) | 2022-09-15 |
Family
ID=61188779
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019541445A Active JP7138112B2 (ja) | 2017-02-01 | 2018-02-01 | 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法 |
| JP2022140682A Pending JP2022179483A (ja) | 2017-02-01 | 2022-09-05 | 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022140682A Pending JP2022179483A (ja) | 2017-02-01 | 2022-09-05 | 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20190345565A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3577237B1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP7138112B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN110382718A (cg-RX-API-DMAC10.html) |
| DK (1) | DK3577237T3 (cg-RX-API-DMAC10.html) |
| FI (1) | FI3577237T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2018141828A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6678201B2 (ja) * | 2018-06-05 | 2020-04-08 | 日清食品ホールディングス株式会社 | 食品情報提供システム、装置、方法及びプログラム |
| GB2599198B (en) * | 2021-06-15 | 2022-12-07 | A3P Biomedical Ab | A method for determining an appropriate time interval for further diagnostic testing for prostate cancer |
| AU2023258468A1 (en) * | 2022-04-27 | 2024-12-12 | Rhy Genetype Pty Ltd | Methods of assessing risk of developing prostate cancer |
| CN120666024A (zh) * | 2025-06-16 | 2025-09-19 | 思达智检有限公司 | 前列腺癌患病及侵袭性风险评估snp标志物、前列腺癌患病及侵袭性风险评估系统及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030219840A1 (en) | 2002-05-24 | 2003-11-27 | Mikolajczyk Stephen D. | Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection |
| JP5631000B2 (ja) | 2006-10-27 | 2014-11-26 | デコード・ジェネティクス・イーエイチエフ | Ｃｈｒ８ｑ２４．２１上の癌感受性変異体 |
| CA2750062A1 (en) | 2009-01-19 | 2010-07-22 | Katrin Stedronsky | Diagnostic assays for prostate cancer using psp94 and psa biomarkers |
| WO2012029080A1 (en) | 2010-08-30 | 2012-03-08 | Decode Genetics Ehf | Sequence variants associated with prostate specific antigen levels |
| EP2611943B1 (en) | 2010-09-03 | 2017-01-04 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| EP2850432A2 (en) * | 2012-05-16 | 2015-03-25 | Phadia AB | Method for indicating the presence or non-presence of prostate cancer |
| RU2669809C2 (ru) * | 2012-11-20 | 2018-10-16 | Пхадиа Аб | Способ прогноза для индивидуумов с раком предстательной железы |
| MY182773A (en) | 2012-11-20 | 2021-02-05 | Phadia Ab | Method for indicating a presence or non-presence of aggressive prostate cancer |
| CA2940445C (en) * | 2014-03-11 | 2021-11-30 | Phadia Ab | Method for detecting a solid tumor cancer |
| CN104946786B (zh) * | 2015-07-21 | 2018-02-27 | 冯宁翰 | 一种检测前列腺癌易感性的方法及试剂盒 |
-
2018
- 2018-02-01 US US16/481,956 patent/US20190345565A1/en not_active Abandoned
- 2018-02-01 FI FIEP18703944.1T patent/FI3577237T3/fi active
- 2018-02-01 WO PCT/EP2018/052473 patent/WO2018141828A1/en not_active Ceased
- 2018-02-01 DK DK18703944.1T patent/DK3577237T3/da active
- 2018-02-01 JP JP2019541445A patent/JP7138112B2/ja active Active
- 2018-02-01 EP EP18703944.1A patent/EP3577237B1/en active Active
- 2018-02-01 CN CN201880009454.1A patent/CN110382718A/zh active Pending
-
2022
- 2022-09-05 JP JP2022140682A patent/JP2022179483A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2891392C (en) | Method for indicating a presence or non-presence of aggressive prostate cancer | |
| US20150094221A1 (en) | Method for Indicating the Presence or Non-Presence of Prostate Cancer | |
| US20200010912A1 (en) | Prognostic method for individuals with prostate cancer | |
| AU2021232712A1 (en) | Method for detecting a solid tumor cancer | |
| US20160326594A1 (en) | Prostate cancer gene profiles and methods of using the same | |
| Liu et al. | Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma | |
| JP2022179483A (ja) | 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法 | |
| KR20260054129A (ko) | 급성 골수성 백혈병의 진단 또는 예후 예측용 유전자 시그니처 | |
| HK1215594B (en) | Method for indicating a presence or non-presence of aggressive prostate cancer | |
| Tainsky | Oncology Biomarkers |